Beijing Luhe hospital
Beijing, 101149, China
NCT Number: NCT01759043
The Rapid Trial is a randomized-controlled trial proposed to test the hypothesis that using a single guiding catheter for left and right coronary angiography and intervention in patients with ST elevation myocardial infarction (STEMI) can reduce procedure time, fluoroscopy time and Cath Lab door to balloon(C2B) time when compared with traditional approach which first underwent coronary angiography with diagnostic catheter followed by guiding catheter selection for intervention.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beijing, 101149, China
a.Cath Lab door to balloon time (C2B)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
using a single transradial guiding catheter for coronary angiography and intervention
diagnostic for coronary angiography and guiding catheter selection for intervention
Time frame: 24hours
Time frame: 180days
Cardiac death Target vessel related myocardial infarction Ischemia driven Target Vessel Revascularization (TVR) Ischemia driven Target Lesion Revascularization (TLR) Definite / probable stent thrombosis by ARC definition
Time frame: 24hours
Time frame: 30days
Time frame: 24hours
Time frame: 24hours
Time frame: 24hours
Time frame: 24hours
Beijing Luhe Hospital
Other
Safety and Feasibility of Using a Single Transradial Guiding Catheter for Both Left and Right Coronary Angiography and Intervention in Patients With ST-segment Myocardial Infarction(RAPID)
Acronym: RAPID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT03677466
Arterial Occlusive Diseases, Arteriosclerosis
Tomsk, Russia
View Trial DetailsNCT03419325
Acute Coronary Syndrome, Arterial Occlusive Diseases
Carolina, Puerto Rico
View Trial DetailsNCT05336435
Acute Coronary Syndrome, Angina Pectoris
Aabenraa, Denmark
View Trial Details